GGrantIndex
← Search

Clinical Protocol and Data Management

$93,589P30FY2019CANIH

University Of Nebraska Medical Center, Omaha NE

Investigators

Linked publications, trials & patents

Paper 39684445Paper 39678719Paper 39605468Paper 39580490Paper 39573886Paper 39456534Paper 39450301Paper 39436320Paper 39420209Paper 39386613Paper 39386448Paper 39384153Paper 39339419Paper 39224072Paper 39219576Paper 39151112Paper 39141488Paper 39130636Paper 39125017Paper 39110778Paper 39107463Paper 39080401Paper 39013847Paper 38974465Paper 38969056Paper 38946943Paper 38900505Paper 38853862Paper 38847506Paper 38775157Paper 38770637Paper 38733583Paper 38712184Paper 38704607Paper 38687198Paper 38683788Paper 38672426Paper 38617282Paper 38603627Paper 38547055Paper 38542184Paper 38514303Paper 38482976Paper 38445903Paper 38437585Paper 38429478Trial NCT03226418Trial NCT03073785Trial NCT02874404Trial NCT02833701Trial NCT02654119Trial NCT02561273Trial NCT02553447Trial NCT02168270Trial NCT01959672Trial NCT01825603Trial NCT01750073Trial NCT01555632Trial NCT01431209Trial NCT01336933Trial NCT01336920Trial NCT01307956Trial NCT01106898Trial NCT01093183Trial NCT01068327Trial NCT01044745Trial NCT01035463Trial NCT00959244Trial NCT00856037Trial NCT00816413Trial NCT00736450Trial NCT00679029Trial NCT00666731Trial NCT00665457Trial NCT00625690Trial NCT00617799Trial NCT00611351Trial NCT00607828Trial NCT00602797Trial NCT00577798Trial NCT00569543Trial NCT00503880Trial NCT00499083Trial NCT00496756Trial NCT00486356Trial NCT00483561Trial NCT00483366Trial NCT00482807Trial NCT00089024Trial NCT00082641Trial NCT00007865Trial NCT00007852Trial NCT00006478Trial NCT00004874Trial NCT00004198Trial NCT00004197Trial NCT00004192Trial NCT00004112Patent 7166704Patent 6680196

Abstract

Project Summary/Abstract: Clinical Protocol and Data Management (CPDM) The Office for Cancer Clinical Research (OCCR), previously referred to as the Centralized Protocol Data Management Unit (CPDMU), is the centralized office that supports clinical cancer research in the Fred and Pamela Buffett Cancer Center (FPBCC) at the University of Nebraska Medical Center (UNMC). The OCCR provides centralized support for investigator-initiated trials (IIT), NCI National Clinical Trials Network and cooperative group trials (Main Member of Alliance, Children's Oncology Group, NRG) multi-institutional consortium trials (BIG10 Cancer Consortium, ACCRU) and industry-sponsored studies. The mission of the OCCR is to assist with the planning, development, conduct, quality assurance, monitoring and compliance of with regulatory agency requirements for clinical trials involving cancer treatments and care, and to provide regulatory support for cancer-related population science studies as well. The OCCR assures the highest quality of research and adherence to relevant regulations by primary upfront coordination of the study and ongoing review of research compliance. The OCCR is a resource within the FPBCC to provide investigators support for all cancer-related clinical research. It is composed of disease-oriented teams (DOT's) that coordinate study management activities (including screening subjects, coordination of treatment and care, and collecting and recording study data), as well as the regulatory management teams responsible for submitting and maintaining all regulatory documents and applications. The OCCR provides investigators with support and study data management, as well as protocol development, monitoring for cooperative group studies, and liaison with federal and industry sponsors and regulatory bodies. The OCCR provides resource support to the FPBCC Scientific Review Committee (SRC), the Data Safety Monitoring Committee (DSMC), and the Audit Committee (AC). The OCCR manages the clinical trials management system (CPDM database) which houses protocol data necessary for planning, reporting and internal oversight, as well as eCRF development and study data reporting in C3D and MediData RAVE. The FPBCC OCCR has been active in NCI initiatives regarding the Clinical Trial Reporting Program (CTRP) and has been an early adopter of C3D and Medidata Rave.

View original record on NIH RePORTER →